SVA logo

SVA
Sinovac Biotech, Ltd.

759
Mkt Cap
$460.27M
Volume
0.00
52W High
$6.47
52W Low
$6.47
PE Ratio
6.03
SVA Fundamentals
Price
$6.47
Prev Close
$6.49
Open
$6.47
50D MA
$6.47
Beta
0.00
Avg. Volume
0.00
P/B
0.11
Loading...
Loading...
News
all
press releases
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Companys previously declared special cash...
News Placeholder
More News
News Placeholder
SINOVAC Reports Unaudited First Half of 2025 Financial Results
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today its unaudited financial results for the six months ended June...
News Placeholder
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal...
News Placeholder
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the Panel) has granted the...
News Placeholder
Sinovac Biotech Updates Antigua Court Order On Board Composition
(RTTNews) - Sinovac Biotech Ltd. (SVA) announced an update on the Antigua High Court's interlocutory order regarding the Company's board composition and corporate actions pending trial. The Company...
News Placeholder
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Courts interlocutory order...
News Placeholder
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2...
News Placeholder
Sinovac:Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr...
News Placeholder
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting...
News Placeholder
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment PR Newswire BOSTON, Nov...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available